Latest Leverage News

Codan Limited reported a robust FY25 with revenue climbing 22% to $674.2 million and net profit rising 27%, driven by strong performances in its Communications and Metal Detection segments.

Sierra Nevada Gold (ASX – SNX) has qualified to bid for exploration licenses in Saudi Arabia’s Arabian Shield, leveraging its regional expertise to tap into a promising new frontier aligned with the Kingdom’s Vision 2030.

SkyCity Entertainment Group reports a 5% revenue decline in FY25 amid economic headwinds and elevated investments, announcing a $240 million equity raise to bolster its balance sheet ahead of the NZICC opening and online gaming launch.

Sonic Healthcare delivered solid FY2025 results with 8% revenue growth and a 7% rise in net profit, setting the stage for an anticipated 19% earnings per share increase in FY2026.

Qube Holdings delivered a robust FY25 performance with underlying revenue up 27.3% and a 7.1% dividend increase, despite a significant impairment of its MITCo investment. The company’s diversified logistics and grain trading operations powered growth amid industrial and weather challenges.

Tryptamine Therapeutics has secured an exclusive agreement with leading neuroscientists to develop a novel EEG-based brain entropy biomarker aimed at enhancing precision psychiatry for its psychedelic drug TRP-8803.

Medical Developments International has reported a remarkable turnaround in FY25, posting a net profit after tax and securing paediatric approval for its flagship product Penthrox in Europe.

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.

Infinity Mining’s re-assay of historic stream sediment samples at its Tanjil Bren Project reveals elevated gold and pathfinder elements, highlighting promising intrusion-related gold system signatures.

Qube Holdings has reported a landmark FY25 with underlying revenue soaring 27.3% to $4.46 billion and earnings rising across all key metrics, despite industrial action and adverse weather disruptions.

Whitehaven Coal reported a robust FY25 with $1.4 billion underlying EBITDA and strong production growth from Queensland acquisitions, maintaining a solid balance sheet and setting ambitious cost-saving targets for FY26.

IDT Australia Limited reported a strong 40.6% increase in revenue to $19.86 million for FY25, driven by growth in advanced therapies and contract disbursements. However, the company’s net loss widened to $8.06 million as it transitions from its ‘Rebuild Strategy’ to a new phase focused on sustainable profitability.